Literature DB >> 16099529

Diagnosis and management of tuberculosis by private practitioners in Manila, Philippines.

Christian Auer1, Jaime Y Lagahid, Marcel Tanner, Mitchell G Weiss.   

Abstract

SETTING: Private for-profit health care providers are prominent in the health system of the Philippines.
OBJECTIVES: To examine the practices of the private practitioners in Malabon, Metropolitan Manila, Philippines, concerning diagnosis and treatment of tuberculosis (TB).
DESIGN: Forty-five private practitioners of Malabon who treat adult TB patients were interviewed.
RESULTS: For diagnosis, most private practitioners relied on the clinical presentation and result of an X-ray. Only 13% of the respondents routinely also asked for sputum examination. Ninety-six percent used X-ray as a tool to monitor treatment. Sixty percent of the respondents prescribed a regimen consisting of isoniazid, rifampicin, pyrazinamide, and ethambutol. Except for rifampicin, over-dosage was common. For re-treatment cases, none prescribed the WHO-recommended re-treatment regimen. The private practitioners perceived the main reasons for patient non-adherence to be the patients' lack of finances to buy drugs and patients' perceived well being after a certain period of treatment. Patients' lack of money was seen as the main obstacle to compliance. The only case holding mechanism mentioned was occasional clinic appointments of the TB patients.
CONCLUSION: Private practices for diagnosis and treatment of TB typically deviate from guidelines. The quality of care among private practitioners needs improvement. Innovative strategies are required.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099529     DOI: 10.1016/j.healthpol.2005.07.004

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  8 in total

1.  Patient views on determinants of compliance with tuberculosis treatment in the eastern cape, South Africa: an application of q-methodology.

Authors:  Jane Murray Cramm; Job van Exel; Valerie Møller; Harry Finkenflügel
Journal:  Patient       Date:  2010-09-01       Impact factor: 3.883

Review 2.  Knowledge of tuberculosis-treatment prescription of health workers: a systematic review.

Authors:  Marieke J van der Werf; Miranda W Langendam; Emma Huitric; Davide Manissero
Journal:  Eur Respir J       Date:  2011-12-19       Impact factor: 16.671

Review 3.  Comparative performance of private and public healthcare systems in low- and middle-income countries: a systematic review.

Authors:  Sanjay Basu; Jason Andrews; Sandeep Kishore; Rajesh Panjabi; David Stuckler
Journal:  PLoS Med       Date:  2012-06-19       Impact factor: 11.069

Review 4.  Prevalence of inappropriate tuberculosis treatment regimens: a systematic review.

Authors:  M W Langendam; M J van der Werf; E Huitric; D Manissero
Journal:  Eur Respir J       Date:  2011-10-17       Impact factor: 16.671

5.  A South African public-private partnership HIV treatment model: viability and success factors.

Authors:  Jude Igumbor; Sophie Pascoe; Shuabe Rajap; Wendy Townsend; John Sargent; Ernest Darkoh
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

6.  Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.

Authors:  Gitau Mburu; Aung Zayar Paing; Nwe Ni Myint; Win Di; Kaung Htet Thu; Mala Ram; Christopher J Hoffmann; Bangyuan Wang; Soe Naing
Journal:  J Int AIDS Soc       Date:  2016-10-25       Impact factor: 5.396

7.  Multi-level predictors of psychological problems among methadone maintenance treatment patients in difference types of settings in Vietnam.

Authors:  Tuan Anh Le; Mai Quynh Thi Le; Anh Duc Dang; Anh Kim Dang; Cuong Tat Nguyen; Hai Quang Pham; Giang Thu Vu; Chi Linh Hoang; Tung Thanh Tran; Quan-Hoang Vuong; Tung Hoang Tran; Bach Xuan Tran; Carl A Latkin; Cyrus S H Ho; Roger C M Ho
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-09-18

8.  Perceptions of the Private Sector for Creating Effective Public-Private Partnerships against Tuberculosis in Metro Manila, Philippines.

Authors:  James Sherpa; Rajendra-Prasad Yadav
Journal:  Am J Trop Med Hyg       Date:  2019-09       Impact factor: 2.345

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.